115 related articles for article (PubMed ID: 2353823)
1. Identification of cytochrome P450IA2 as a human autoantigen.
Manns MP; Griffin KJ; Quattrochi LC; Sacher M; Thaler H; Tukey RH; Johnson EF
Arch Biochem Biophys; 1990 Jul; 280(1):229-32. PubMed ID: 2353823
[TBL] [Abstract][Full Text] [Related]
2. Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450IA2.
Lambrecht RW; Sinclair PR; Gorman N; Sinclair JF
Arch Biochem Biophys; 1992 May; 294(2):504-10. PubMed ID: 1567206
[TBL] [Abstract][Full Text] [Related]
3. Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo.
Manns M; Zanger U; Gerken G; Sullivan KF; Meyer zum Büschenfelde KH; Meyer UA; Eichelbaum M
Hepatology; 1990 Jul; 12(1):127-32. PubMed ID: 2373473
[TBL] [Abstract][Full Text] [Related]
4. Metabolic deactivation of furylfuramide by cytochrome P450 in human and rat liver microsomes.
Shimada T; Yamazaki H; Shimura H; Tanaka R; Guengerich FP
Carcinogenesis; 1990 Jan; 11(1):103-10. PubMed ID: 2403855
[TBL] [Abstract][Full Text] [Related]
5. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
6. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
[TBL] [Abstract][Full Text] [Related]
7. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
Kim SG; Reddy SL; States JC; Novak RF
Mol Pharmacol; 1991 Jul; 40(1):52-7. PubMed ID: 1857340
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.
McManus ME; Burgess WM; Veronese ME; Huggett A; Quattrochi LC; Tukey RH
Cancer Res; 1990 Jun; 50(11):3367-76. PubMed ID: 2334931
[TBL] [Abstract][Full Text] [Related]
9. Inducing effect of oxfendazole on cytochrome P450IA2 in rabbit liver. Consequences on cytochrome P450 dependent monooxygenases.
Gleizes C; Eeckhoutte C; Pineau T; Alvinerie M; Galtier P
Biochem Pharmacol; 1991 Jun; 41(12):1813-20. PubMed ID: 2039538
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I.
Gebre-Medhin G; Husebye ES; Gustafsson J; Winqvist O; Goksøyr A; Rorsman F; Kämpe O
FEBS Lett; 1997 Aug; 412(3):439-45. PubMed ID: 9276443
[TBL] [Abstract][Full Text] [Related]
11. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P450IA1.
De Matteis F; Dawson SJ; Boobis AR; Comoglio A
Mol Pharmacol; 1991 Nov; 40(5):686-91. PubMed ID: 1944239
[TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450s as autoantigens.
Manns MP; Johnson EF
Methods Enzymol; 1991; 206():210-20. PubMed ID: 1784210
[TBL] [Abstract][Full Text] [Related]
13. Dynamic interactions of rabbit liver cytochromes P450IA2 and P450IIB4 with cytochrome b5 and NADPH-cytochrome P450 reductase in proteoliposomes.
Yamada M; Ohta Y; Bachmanova GI; Nishimoto Y; Archakov AI; Kawato S
Biochemistry; 1995 Aug; 34(32):10113-9. PubMed ID: 7640265
[TBL] [Abstract][Full Text] [Related]
14. Identification of a functionally conserved surface region of rat cytochromes P450IA.
Edwards RJ; Singleton AM; Murray BP; Murray S; Boobis AR; Davies DS
Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):749-57. PubMed ID: 1716884
[TBL] [Abstract][Full Text] [Related]
15. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2.
Raucy JL; Lasker JM; Lieber CS; Black M
Arch Biochem Biophys; 1989 Jun; 271(2):270-83. PubMed ID: 2729995
[TBL] [Abstract][Full Text] [Related]
16. A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitis.
Kiffel L; Loeper J; Homberg JC; Leroux JP
Biochem Biophys Res Commun; 1989 Feb; 159(1):283-9. PubMed ID: 2466461
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
18. Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro and in vivo. Evidence that hexachlorobenzene is a weak Ah receptor agonist.
Hahn ME; Goldstein JA; Linko P; Gasiewicz TA
Arch Biochem Biophys; 1989 Apr; 270(1):344-55. PubMed ID: 2539049
[TBL] [Abstract][Full Text] [Related]
19. Developmental expression of rabbit cytochrome P450 CYP1A1, CYP1A2 and CYP3A6 genes. Effect of weaning and rifampicin.
Pineau T; Daujat M; Pichard L; Girard F; Angevain J; Bonfils C; Maurel P
Eur J Biochem; 1991 Apr; 197(1):145-53. PubMed ID: 2015817
[TBL] [Abstract][Full Text] [Related]
20. The inducibility and catalytic activity of cytochromes P450c (P450IA1) and P450d (P450IA2) in rat tissues.
Sesardic D; Cole KJ; Edwards RJ; Davies DS; Thomas PE; Levin W; Boobis AR
Biochem Pharmacol; 1990 Feb; 39(3):499-506. PubMed ID: 2306262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
